University of Vermont

College of Medicine

Department of Medicine

Cardiovascular Medicine

Bio for Harold L. Dauerman, M.D.
Harold L. Dauerman, M.D.

Harold L. Dauerman, M.D.

Professor of Medicine
Cardiovascular Medicine, Department of Medicine

Contact Information
Office Location:
Medicine-Cardiology, McClure Wing, 111 Colchester Avenue, Burlington, VT 05401


Medical School - Harvard Medical School, Boston, MA

Research Interests

Dr. Dauerman has used clinical trials, investigator-initiated studies, and multi-center registry studies to elucidate optimal interventional cardiology treatment options for high risk patients, including the elderly, women, and patients with ST elevation myocardial infarction, cardiogenic shock, and aortic valve disease.

He led two trials serving as national co-principal investigator: the EDUCATE trial, which studied patient compliance with dual antiplatelet therapy after drug eluting stent placement, and the BOSS trial, which randomized patients undergoing cardiac catheterization to different hydration regimens to prevent contrast-related kidney injury.  Dr. Dauerman is currently leading UVM clinical trials of renal denervation, bioabsorbable drug eluting stents, and transcatheter aortic valve replacement (TAVR).

Academic Appointments

Professor of Medicine
Professor of Surgery


Dauerman HL, Sobel BE. Synergistic treatment of ST segment elevation acute myocardial infarction with pharmacoinvasive recanalization. J Am Coll Cardiol. 2003;42:646-51.

Aggarwal A, Schneider DJ, Sobel BE, Dauerman HL. Temporal differences in inflammation among diabetic patients undergoing coronary stenting. Am J Cardiol. 2003;92:924-29.

Dauerman HL, Applegate RJ, Cohen DJ.  Vascular closure devices: the second decade. J Am Coll Cardiol. 2007;50:1617-26.

Dauerman HL. PCI pharmacology: From a triangle to a square. J Am Coll Cardiol. 2008;51:698-700.

Ahmed BA, Malenka DL, Piper W, Kellet M, Herne M, Dauerman HL. Significantly improved vascular complications among women undergoing PCI: A report from the Northern New England Registry. Circ Cardiovasc Interv. 2009;2:423-9.

Dauerman HL, Bhatt DB, Smyth SS, French PA, Becker RC.  Bridging the gap between clinical trials and applications of antiplatelet therapy for the elderly. Am Heart J. 2010;159:508-17.

Solomon RJ, Dauerman HL. Contrast induced acute kidney injury: A clinician’s update. Circulation. 2010;122:2451-5.

Dauerman HL, Rao SV, Resnic F, Applegate RG. Bleeding avoidance strategies: Consensus and controversy. J Am Coll Cardiol. 2011;58:1-10.

Mueller E, Prabhu W, Desarno M, Sundaran P, Dauerman HL. Bleeding complications with regional adaptation of a prolonged bivalirudin regimen for ST elevation acute myocardial infarction. Am J Cardiol. 2012;110:1607-12.

Rodés-Cabau J, Dauerman HL, Cohen MG, Mehran R, Small EM, Smyth SS, Costa MA, Mega JL, O’Donoghue ML, Ohman EM, Becker RC.  Antithrombotic treatment in transcatheter aortic valve implantation: Insights for cerebrovascular and bleeding events. J Am Coll Cardiol. 2013;62:2349-59.

Ahmed B, Dauerman HL. Women, bleeding and coronary intervention. Circulation. 2013;127:641-9.

Dauerman HL. Deconstructing the language of bleeding. J Am Coll Cardiol. 2014;63:1876-8.

Tian J, Dauerman H, Toma C, et al. Prevalence and characteristics of thin-cap fibroatheroma and degree of coronary artery stenosis: An optical coherence tomography, intravascular ultrasound, and angiographic study. J Am Coll Cardiol. In press.